135 related articles for article (PubMed ID: 17179995)
1. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
[TBL] [Abstract][Full Text] [Related]
2. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
Conrad C; Vianna C; Schultz C; Thal DR; Ghebremedhin E; Lenz J; Braak H; Davies P
J Neurochem; 2004 Apr; 89(1):179-88. PubMed ID: 15030402
[TBL] [Abstract][Full Text] [Related]
3. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
4. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
[TBL] [Abstract][Full Text] [Related]
5. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
Mukherjee O; Kauwe JS; Mayo K; Morris JC; Goate AM
BMC Genet; 2007 Jan; 8():3. PubMed ID: 17266761
[TBL] [Abstract][Full Text] [Related]
6. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
8. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.
Johansson A; Zetterberg H; Hampel H; Buerger K; Prince JA; Minthon L; Wahlund LO; Blennow K
Dement Geriatr Cogn Disord; 2005; 20(6):367-74. PubMed ID: 16192727
[TBL] [Abstract][Full Text] [Related]
10. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
Blomqvist ME; Andreasen N; Bogdanovic N; Blennow K; Brookes AJ; Prince JA
Neurosci Lett; 2004 Apr; 358(3):220-2. PubMed ID: 15039120
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal stability of CSF biomarkers in Alzheimer's disease.
Blennow K; Zetterberg H; Minthon L; Lannfelt L; Strid S; Annas P; Basun H; Andreasen N
Neurosci Lett; 2007 May; 419(1):18-22. PubMed ID: 17482358
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
14. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
[TBL] [Abstract][Full Text] [Related]
15. Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Kornhuber J; Frölich L; Heuser I; Peters O; Schulz JB; Schwab SG; Maier W
Neurosci Lett; 2008 Jul; 440(1):68-71. PubMed ID: 18541377
[TBL] [Abstract][Full Text] [Related]
16. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
17. Association of SORL1 gene variants with Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Teipel SJ; Kornhuber J; Frölich L; Heuser I; Peters O; Wiese B; Kaduszkiewicz H; van den Bussche H; Hüll M; Kurz A; Rüther E; Henn FA; Maier W
Brain Res; 2009 Apr; 1264():1-6. PubMed ID: 19368828
[TBL] [Abstract][Full Text] [Related]
18. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.
Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2008; 25(4):317-20. PubMed ID: 18319590
[TBL] [Abstract][Full Text] [Related]
19. Single molecule profiling of tau gene expression in Alzheimer's disease.
Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
[TBL] [Abstract][Full Text] [Related]
20. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
